 |
|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
- Therapeutics-Clinical (Early) - - - ,
- - -
4SC - Martinsried,
Germany - drug discovery and development
- A - A - ,
- - -
Aastrom Biosciences - Ann Arbor,
MI - patient-specific cell-based therapies
Acambis - Cambridge,
UK; Canton, MA - vaccines for the treatment of infectious diseases
Accentia Biopharmaceuticals - Tampa,
FL ; Tampa, FL - acquisition of late stage pharmaceuticals and improvement through new delivery technologies
Achillion Pharmaceuticals - New Haven,
CT - small molecule therapeutics for infectious diseases
Acologix - Hayward,
CA - biology-based drug discovery and development
Acorda Therapeutics - Hawthorne,
NY - spinal cord injury-based therapeutics
ActivBiotics - Lexington,
MA - antibacterial therapeutics
Active Biotech - Lund,
Sweden - immunology-based pharmaceuticals
Acuity Pharmaceuticals - Philadelphia,
PA - siRNA therapeutics
Acusphere - Watertown,
MA - drug delivery using porus microparticles
Adenosine Therapeutics - Charlottesville,
VA - adenosine receptor-based therapeutics
Aderis Pharmaceuticals - Hopkinton,
MA ; Richmond,VA - development of small molecule therapeutics for CNS, cardiovascular and renal diseases
Adolor - Exton,
PA - pain relief therapeutics
Advanced Life Sciences - Woodridge,
IL - infectious disease, oncology and inflammation therapeutic development through early clinical stages
Advanced Viral Research (ADVR) - Yonkers,
NY - peptide nucleic acid based therapeutics
Advancis Pharmaceutical - Germantown,
MD - anti-infective therapeutics
Adventrx Pharmaceuticals - San Diego,
CA - pharmaceutical research through licensing agreements
Alexion Pharmaceuticals - Cheshire,
CT - human antibody therapeutics
Alfacell - Bloomfield,
NJ - RNase therapeutics
Alizyme - Cambridge,
UK - drug development, focusing on obesity and diabetes
Allos Therapeutics - Westminster,
CO - cancer therapeutics
AlphaVax - Research Triangle Park,
NC - vaccine-based therapeutics
Alseres Pharmaceuticals - Hopkinton,
MA ; Woburn, MA - development stage CNS and cancer therapeutics
Alteon - Parsippany,
NJ - anti-aging therapeutics
Amarillo Biosciences - Amarillo,
TX - low-dose oral and topical interferon alpha
Amarin - London,
UK; Mill Valley, CA ; Sweden - therapeutics for neurology and pain management
AmCyte - Santa Monica,
CA - diabetes treatments using transplanted islet cells
Amicus Therapeutics - Cranbury,
NJ - small molecule therapeutics for the treatment of human genetic diseases
Angstrom Pharmaceuticals - San Diego,
CA - Recptor/ligand-based drug discovery
AnorMED - Vancouver,
British Columbia UK - small molecule therapeutics
Antigenics - New York,
NY ; Lexington, MA - therapeutics for the treatment of cancer, infectious diseases and autoimmune disorders
Antisense Therapeutics - Melbourne,
Australia - antisense-based therapeutics
Antisoma - London,
UK - preclinical and clinical stage cancer therapeutics company
Aphios - Woburn,
MA - infectious disease and cancer therapeutics
Aphton - Miami,
FL - cancer immunotherapeutics
Applied Genetic Technologies - Alachua,
FL - gene therapy using viral vectors
Aptamera - Louisville,
KY - DNA aptamer-based cancer therapeutics
Arakis - Little Chesterford,
Essex UK - rheumatology and oncology focused drug discovery and development
Archemix - Cambridge,
MA - aptamer-based therapeutics
Ardana Bioscience - Edinburgh,
Scotland UK - therapeutics for reproductive health
Argos Therapeutics - Durham,
NC - immunotherapeutics
Ariad Pharmaceuticals - Cambridge,
MA - small molecule therapeutics that regulate cell signaling
ArQule - Woburn,
MA - drug discovery
ARYx Therapeutics - Santa Clara,
CA - redesign of proven therapeutics to reduce toxicity
AtheroGenics - Alpheretta,
GA - development small molecule therapeutics for chronic inflammatory diseases
Attenuon - San Diego,
CA - cancer therapeutics
Avant Immunotherapeutics - Needham,
MA - develops immunotherapeutics
Avera Pharmaceuticals - San Diego,
CA - neuroscience therapeutics
AVI BioPharma - Portland,
OR Corvallis,OR; Portland, OR - antisense-based therapeutics
Avontec - Martinsried,
Germany - nucleic-acid-based anti-inflammatory therapeutics
Axonyx - New York,
NY - acquisition and development of memory-related therapeutics
- B - B - ,
- - -
BCY LifeSciences - Toronto,
Ontario Canada - late stage pharmaceutical development company
BioCryst Pharmaceuticals - Birmingham,
AL - structure-based drug design
Biofrontera Pharmaceuticals - Leverkusen,
Germany - drug discovery and development
BioMimetic Pharmaceuticals - Franklin,
TN - protein therapeutic products for tissue engineering (perdiodontal and orthopedic)
Biomira - Bellevue,
WA ; Edmonton, Alberta, Canada ; Tucson, AZ - immunotherapy and cancer therapeutics (cancer vaccines)
BioNumerik - San Antonio,
TX - cancer therapeutics
BioSante Pharmaceuticals - Lincolnshire,
IL - hormone therapeutics
BioSpecifics Technologies - Lynbrook,
NY - wound healing and tissue remodeling therapeutics
Biosyn - Huntingdon Valley,
PA - infectious disease and reproductive health therapeutics
Biota Holdings - Notting Hill ,
VIC Australia - antiviral therapeutics
Biothera - Eagan,
MN - complex carbohydrate biopolymers therapeutics and products
BioXell - Milan,
Italy - drug discovery platforms based on Vitamin D3 and TREM receptors
- C - C - ,
- - -
Callisto Pharmaceuticals - New York,
NY ; Doylestown, PA - developing therapeutics for multiple myeloma, colon cancer and for gastrointestinal† inflammation
CancerVax Corp. - Carlsbad,
CA ; Marina Del Ray, CA - therapeutic cancer vaccines and angiogenesis-controlling antibodies
Cardiome Pharma - Vancouver,
British Columbia Canada - cardiovascular drug development
Cel-Sci - Vienna,
VA ; Baltimore, MD - cancer immunotherapeutics
Cell Genesys - South San Francisco,
CA ; San Diego, CA; Memphis, TN - human gene therapy; viral therapeutics
Cellegy Pharmaceuticals - South San Francisco,
CA - therapeutics targeting gastroenterology conditions and sexual dysfunction using topical formulations and nitric oxide donor technologies
Cellerant Therapeutics - Palo Alto,
CA - hematopoietic stem cell-based therapeutics
Celmed BioSciences - St. Laurent,
Canada - oncology and hematology therapeutics and cell therapy
CeNeS Pharmaceuticals - Cambridge,
UK - drug development in the areas of pain, anaesthesia and neurology.
Ceregene - San Diego,
CA - genetic therapeutics for the treatment of neurological disorders
Cerus - Concord,
CA - therapeutics based on the inhibition of nucleic acid replication
ChemGenex Pharmaceuticals - Menlo Park,
CA - chemical genomics-based cancer therapeutics
ChemoCentryx - Mountain View,
CA - chemokine-based therapeutics
Chrysalis BioTechnology - Galveston,
TX - tissue repair therapeutics
Chugai Pharma USA - San Diego,
CA - human therapeutics for the treatment of cardiovascular disease and cancer
Clavis Pharma - Oslo,
Norway - Lipid Vector Technology for the improvement of therapeutics
Coley Pharmaceutical Group - Wellesley,
MA - immuno-stimulating therapeutics
Collgard Biopharmaceuticals - Atlanta,
GA - tissue therapeutics
CombinatoRx - Boston,
MA - multi-drug approach therapeutics
ConjuChem - Montreal,
Quebec Canada - bioconjucation technologies for (primarily) peptide therapeutics
Corautus Genetics - Atlanta,
GA - DNA-based therapeutics for the treatment of vascular diseases
Corgentech - South San Francisco,
CA - therapeutics based on transcription factor decoys
Cortex Pharmaceuticals - Irvine,
CA - neurological disease therapeutics
CryoCor - San Diego,
CA - cryogenic ablation medical technology
Cubist Pharmaceuticals - Lexington,
MA ; Slough, Berkshire, UK - antimicrobial drug development
Curacyte - Munich,
Germany; Chapel Hill, NC. - biopharmaceutical company
CuraGen - New Haven,
CT - genomics-based drug discovery
CV Therapeutics - Palo Alto,
CA - small molecule therapeutics for cardiovascular disease
Cyclacel - Dundee,
Scottland UK - small molecule therapeutics targeting cell proliferation
Cypress Bioscience - San Diego,
CA - therapeutics for fibromyalgia syndrome
Cytogen - Princeton,
NJ - oncology drugs and prostate cancer treatments
CytoGenix - Houston,
TX - disease therapeutics based on ssDNA expression system (translational regulation)
Cytokinetics - South San Francisco,
CA - small molecule drug discovery programs in cytoskeletal pharmacology, specifically for treating cancer
- D - D - ,
- - -
DARA BioSciences - Raleigh,
NC - small molecule therapeutics
Debiopharm - Lausanne,
Switzerland - development of in-licensed therapeutics
Dendreon - Seattle,
WA - monoclonal antibody therapeutics for cancer treatments
Discovery Labs - Doylestown,
PA - respiratory therapeutics
DOR BioPharma - Ewing,
NJ - oral and mucosal drug delivery
Dragon Pharmaceuticals - Vancouver,
B.C. Canada - genetically engineered human proteins for therapeutic use
Dyax - Cambridge,
MA ; Liege, Belgium - phage display-based drug discovery
Dynavax - Berkeley,
CA - development of therapeutics based on "immunostimulatory sequences"
- E - E - ,
- - -
EMD Pharmaceuticals - Durham,
NC - cancer and diabetes therapeutics
Encysive Pharmaceuticals - Houston,
TX - small molecule drug development for cardiovascular and inflammatory dieseases
Endovasc Ltd, Inc. - Montgomery,
TX - Phase I and II clinical development of therapeutics for cardiovascular and metabolic disease
Enhance Biotech - New York,
NY - therapeutics aimed at the lifestyle market (in-licenses products at the clinical trial stage)
EntreMed - Rockville,
MD - cancer therapeutics
Enzo Biochem - Farmingdale,
NY - life science reagents, gene and immune regulation-based therapeutics, and clinical diagnostics services
Epeius Biotechnologies - Los Angeles,
CA - targeted injected delivery systems for therapeutics
Epigenesis Pharmaceuticals - Cranbury,
NJ - antisense drugs for the treatment of respiratory diseases
Epimmune - San Diego,
CA - epitope-based pharmaceuticals
EpiTan - Melbourne,
Australia - dermatology therapeutics
EPIX Pharmaceuticals - Lexington,
MA - in silico drug discovery and development
ESP Pharma - Edison,
NJ - acquisition and development of commercially available therapeutics and late-stage development specialty drugs
Evotec OAI - Hamburg,
Germany; Abingdon, UK - therapeutics and services (CRO)
eXegenics - Dallas,
TX - drug development through acquisition of late stage pre-clinical or early stage clinical compounds
Exelixis - South San Francisco,
CA - human therapeutics based on model genetic organisms
Eyetech Pharmaceuticals - New York,
NY - aptamer therapeutics for macular degeneration
- F - F - ,
- - -
Favrille - San Diego,
CA - develops patient-specific immunotherapeutics for lymphoma and diseases of the immune system
Forbes Medi-Tech - Vancouver,
British Columbia Canada - cardiovascular therapeutics and nutraceuticals
- G - G - ,
- - -
Gamida-Cell - Jerusalem,
Israel - stem cell therapeutics
Gastrotech Pharma - Copenhagen,
Denmark - gastrointestinal peptide hormone-based therapeutics
Genaera - Plymouth Meeting,
PA - respiratory genomics and drug discovery; natural product drug discovery
Genelabs Technologies - Redwood City,
CA - SLE (Lupus) therapeutics
Genitope - Fremont,
CA - cancer immunotherapeutics
Genmab - Copenhagen,
Denmark - human antibody therapeutics
GenVec - Gaithersburg,
MD - gene-based(gene therapy) medicines
Genzyme Molecular Oncology - Framingham,
MA - developing cancer therapeutics based on cancer vaccines, angiogenesis inhibitors and cancer pathway regulators
GlobeImmune - Aurora,
CO - modulation of immune system
GlycoGenesys - Boston,
MA - glycobiology therapeutics
GPC Biotech - Martinsried,
Germany - anticancer therapeutics drug discovery and development
- H - H - ,
- - -
H3 Pharma - Montreal,
Quebec Canada - development of in-licensed therapeutics through clinical trials
Halozyme Therapeutics - San Diego,
CA - recombinant human enzyme therapeutics
Hollis-Eden Pharmaceuticals - San Diego,
CA - develops Immune Regulating Hormones as therapeutics
Hunter-Fleming - Bristol,
UK - inflammatory neurodegenerative disease therapeutics
- I - I - ,
- - -
Icagen - RTP,
NC - ion channel-based therapeutics
IDM Pharma - Irvine,
CA - immunotherapeutics for the treatment of cancer
Igeneon - Vienna,
Austria - cancer immunotherapeutics
ImClone Systems - New York,
NY - monoclonal antibody cancer therapeutics
Immtech International - Vernon Hills,
IL - develops oral drugs for infectious diseases
ImmunoGen - Cambridge,
MA - monoclonal antibody cancer therapeutics
Immusol - San Diego,
CA - drug target discovery-based biopharmaceutical company
Incyte - Wilmington,
DE - small molecule drug discovery and genomics databases and libraries
Indevus Pharmaceuticals - Lexington,
MA - acquisition and development of late stage clinical compounds
Inex Pharmaceuticals - Burnaby,
British Columbia Canada - cancer therapeutics and drug delivery systems
Inflabloc Pharmaceuticals - Salt Lake City,
UT - inflammatory disorder pharmaceuticals
Inflazyme Pharmaceuticals - Vancouver,
British Columbia Canada - inflammatory disease therapeutics
Ingenium Pharmaceuticals - Martinsried,
Germany - drug discovery
Inhibitex - Alpharetta,
GA - antibody-based anti-infective therapeutics
Innogenetics - Ghent,
Belgium - molecular diagnostics and therapeutic vaccines
Inovio - San Diego,
CA - DNA-based vaccines and immunotherapies
InSite Vision - Alameda,
CA - ophthalmic diagnositcs and drug delivery
Inspire Pharmaceuticals - Durham,
NC - therapeutics for the trestment of mucosal deficiency diseases
Intercell - Vienna,
Austria - vaccine therapeutics
IntraBiotics Pharmaceuticals - Mountain View,
CA - antimicrobial and oncology therapeutics
Introgen Therapeutics - Austin,
TX ; Houston, TX - gene-based therapeutics
Ionix Pharmaceuticals - Cambridge,
UK - analgesic therapeutics
Ipsat Therapies - Espoo,
Finland - prevention of antibiotic resistance
IriSys - San Diego,
CA - preclinical and early clinical pharmaceutical services
Isotechnika - Edmonton,
Alberta Canada; Scottsdale, AZ - immunosuppressive therapeutics
Ista Pharmaceuticals - Irvine,
CA - Hyaluronidase-based therapeutics for eye diseases
- J - J - ,
- - -
- K - K - ,
- - -
Kosan Biosciences - Hayward,
CA - polyketides-based drug discovery
KuDOS Pharmaceuticals - Cambridge,
UK - DNA damage therapeutics
- L - L - ,
- - -
La Jolla Pharmaceuticals - San Diego,
CA - development of therapeutics for antibody-mediated autoimmune diseases (lupus)
LAB International - Laval,
Quebec Canada - inhalation drug therapeutics
Living Cell Technologies - Adelaide,
Australia - encapsulated living cell therapeutics
- M - M - ,
- - -
MaxCyte - Rockville,
MD - flow electroporation for the incorporation of therapeutics into cells
Maxim Pharmaceuticals - San Diego,
CA - histamine-related drug therapies
Medarex - Princeton,
NJ ; Milpitas, CA - monoclonal antibody-based therapeutics
MediciNova - San Diego,
CA - store-operated calcium channels-based drug development
Medinox - Carlsbad,
CA - Nitric oxide neutralizer-based therapeutics
Memory Pharmaceuticals - Montvale,
NJ - neuropharmaceuticals
Metabasis Therapeutics - San Diego,
CA - liver disease/diabetes drug development
MethylGene - Montreal,
Quebec Canada - cancer and infectious diseases drug discovery
MGI Pharma - Bloomington,
MN - oncology therapeutic development and manufacturing
Micromet - Munich,
Germany - antibody therapeutics
Microscience - Wokingham,
Berkshire UK - vaccines and immunotherapeutics
MIGENIX - Vancouver,
British Columbia Canada - anti-infective therapeutics
- N - N - ,
- - -
NeoPharm - Lake Forest,
IL - cancer therapeutics
NeoRx - Seattle,
WA - targeted delivery of cancer therapeutics
Neovacs - Paris,
France - immunotherapeutics
Neurobiological Technologies - Emeryville,
CA - neuroscience therapeutics
Neurochem - Laval,
Quebec Canada - neurological therapeutics
Neurocrine Biosciences - San Diego,
CA - discovery and development of neurological disease therapeutics
Neurogen - Branford,
CT - small molecule drug discovery for neurological, inflammatory, pain and metabolic disorders
NeurogesX - San Carlos,
CA - therapeutics for the treatment of pain and nerve signaling disorders
Newron Pharmaceuticals - Bresso (Milan),
Italy - CNS and pain pharmaceuticals
NicOx - Sophia Antipolis,
France - nitric oxide-based therapeutics
NitroMed - Bedford,
MA - nitric oxide-based therapeutics
Northwest Biotherapeutics - Bothell,
WA - cancer drug development
Nova BioGenetics - Atlanta,
GA - antibiotic therapeutics
NovaRX - San Diego,
CA - vaccine-based cancer therapeutics
Novimmune - Geneva,
Switzerland - development of human monoclonal antibody therapeutics for immune and inflammation related diseases
NPS Pharmaceuticals - Salt Lake City,
UT - small molecule and recombinant protein therapeutics
Nuvelo - San Carlos,
CA - therapeutics discovery and development
Nventa Biopharmaceuticals - San Diego,
CA - cancer and viral infection therapeutics
- O - O - ,
- - -
OncoGenex Technologies - Vancouver,
British Columbia Canada - cancer therapeutics
OncoMab - W¸rzburg,
Germany - human antibody therapeutics
OncoTherapy Science - Kanagawa,
Japan - cancer therapeutics
Onyx Pharmaceuticals - Emeryville,
CA - human disease therapuetics
Optimer Pharmaceuticals - San Diego,
CA - oligosaccharide-based therapeutics
Oscient Pharmaceuticals - Waltham,
MA - genomics-based pharmaceuticals and genomic services
OSI Pharmaceuticals - Melville,
NY ; Boulder, CO; Uxford, UK - pharmaceutical development for cancer and diabetes treatments
Osiris Therapeutics - Baltimore,
MD - cellular therapeutics for the treatment of damaged and diseased tissue
Oxford Biomedica - Oxford,
UK - gene-based therapeutics
Oxigene - Waltham,
MA - cancer therapeutics (vascular targeting)
- P - P - ,
- - -
Pain Therapeutics - South San Francisco,
CA - painkiller development
Palatin Technologies - Cranbury,
NJ - developing melanocortin-based therapeutics
Panacos Pharmaceuticals - Gaithersburg,
MD - antiviral therapeutics
Peninsula Pharmaceuticals - Alameda,
CA - anti-infective therapeutics
Peptimmune - Cambridge,
MA Cambridge, MA - immunotherpeutics
Peregrine Pharmaceuticals - Tustin,
CA - cancer therapeutics
Pharis Biotech - Hanover,
Germany - peptide drug discovery and development
Pharmacyclics - Sunnyvale,
CA Sunnyvale, CA - small molecule (texaphyrins)-based pharmaceuticals
PharmaMar - Madrid,
Spain - cancer therapeutics derived from marine animals
Pharmaxis - Sydney,
Australia - therapeutics for the treatment of chronic respiratory and autoimmune diseases
Pharmos - Iselin,
NJ ; Rehovot, Israel - CNS therapeutics
Pherin Pharmaceuticals - Redwood City,
CA - CNS pharmaceuticals which act via the vomeronasal organ (pheromone sensory organ)
Point Therapeutics - Boston,
MA - small molecule therapeutics for the treatment of cancer, hematopoietic disorders and infectious diseases
Pozen - Chapel Hill,
NC - migraine therapeutics, focusing on drug development
Prima BioMed - Victoria,
Australia - cancer therapeutics
ProMetic Life Sciences - Montreal,
Quebec Canada - therapeutics and bioseparation technology
Proneuron Biotechnologies - Los Angeles,
CA ; Ness-Ziona, Israel - CNS disease drug development
Provectus Pharmaceuticals - Knoxville,
TN - therapeutics for cancer and skin diseases
- Q - Q - ,
- - -
- R - R - ,
- - -
Reata Discovery - Dallas,
TX - small molecule therapeutics for the treatment of cancer, inflammation and neurodegenerative disease.
Regeneron Pharmaceuticals - Tarrytown,
NY ; Rensselaer, NY - therapeutics for treatment of obesity, rheumatoid arthritis, and cancer
RegeneRx Biopharmaceuticals - Bethesda,
MD - wound healing therapeutics
Renovis - South San Francisco,
CA - neurological therapeutics
Renovo - Manchester,
UK - scar prevention therapeutics
Revotar Biopharmaceuticals - Henningsdorf,
Germany - develops small molecule anti-inflammatory drugs
- S - S - ,
- - -
Samaritan Pharmaceuticals - Las Vegas,
NV - drug discovery and development
Santhera Pharmaceuticals - Basel,
Switzerland; Heidelberg, Germany - small molecule microarrays (chemical genomics) for drug target screening
SciClone Pharmaceuticals - San Mateo,
CA - infectious disease and cancer therapeutics
Seattle Genetics - Bothell,
WA - monoclonal antibody-based therapeutics
Sequella - Rockville,
MD - tuberculosis research and therapeutics (through in-licensing)
Spectrum Pharmaceuticals - Irvine,
CA - in-licensing, clinical development and commercialization of oncology drugs
StemCells - Palo Alto,
CA - human neural stem cell therapeutics
SuperGen - Dublin,
CA - oncology therapeutics (generally acquired in late stage development)
Symbollon Pharmaceuticals - Framingham,
MA - molecular iodine-based therapeutics
Synta Pharmaceuticals - Lexington,
MA - cancer and immune disorder-targeted drug discovery
- T - T - ,
- - -
TaiGen Biotechnology - Taipei,
Taiwan - cancer and immune disease therapeutics
Tanox - Houston,
TX ; San Diego, CA - asthma, allergy and inflammation therapeutics
Telik - Palo Alto,
CA - discovery and development of small-molecule biopharmaceuticals
Theratechnologies - Montreal,
Quebec Canada - endocrine and metabolic disorder therapeutics
Threshold Pharmaceuticals - Redwood City,
CA - conjugation chemistry-based pharmaceuticals for the treatment of cancer
Tissue Repair Company - San Diego,
CA - tissue repair gene therapy
TolerRx - Cambridge,
MA - therapeutics that induce or remove immunological tolerance
Tolerx - Cambridge,
MA - immune system therapeutics
TorreyPines Therapeutics - La Jolla,
CA - developing small molecule drugs for neurodegenerative disorders
Transgene - Strasbourg Cedex,
France - cancer immunotherapeutics
Trimeris - Durham,
NC - HIV therapeutic development
Twinstrand Therapeutics - North Vancouver,
British Columbia Canada - develops prodrugs for the treatment of cancer and viral and bacterial infections
- U - U - ,
- - -
Unigene Laboratories - Fairfield,
NJ - oral and nasal delivery of large-market peptide drugs
- V - V - ,
- - -
Valentis - Burlingame,
CA - gene-based human therapeutics
Vasogen - Mississauga,
Ontario Canada - immune modulation therapies for the treatment of cardiovascular disease
VaxGen - Brisbane,
CA - vaccine therapeutics
VDDI Pharmaceuticals - Brentwood,
TN ; Kalamazoo, MI ; Cary, NC ; Glastonbury, CT - inlicensing of drug candidates and development through phase 2 clinical trials
Vela Pharmaceuticals - Lawrenceville,
NJ - neurological therapeutics
Vernalis - Wokingham,
UKWokingham, UK - neuroscience and CNS therapeutics
Vical - San Diego,
CA - "naked DNA" gene delivery for disease treatment
Vicuron Pharmaceuticals - Fremont,
CA - antibiotic and antifungal therapeutics
Vion Pharmaceuticals - New Haven,
CT - cancer therapeutics
Viragenics - Plantation,
FL - avian transgenics subsidiary of Viragen
ViRexx Medical - Edmonton,
Alberta Canada - cancer therapeutics
VIRxSYS - Gaithersburg,
MD - gene therapeutics
Viventia Biotech - Toronto,
Ontario Canada - monoclonal antibody cancer therapeutics
Vyrex - La Jolla,
CA - small molecule therapeutics
- W - W - ,
- - -
Wilex - Munich,
Germany - small molecule and antibody cancer therapeutics
- X - X - ,
- - -
Xanthus Life Sciences - Cambridge,
MA ; Montreal, Quebec, Canada - non-pharmacogenomics-based personalized medicine
- Y - Y - ,
- - -
YM BioSciences - Mississauga,
Ontario Canada - clinical development of cancer therapeutics
- Z - Z - ,
- - -
|
|
